Data through close

Vanna exposure extremes

Which liquid chains had the largest positive and negative volatility-sensitive delta exposure on Nov 17, 2026?

Modeled net vanna normalized to 100,000 open contracts. The 25 most positive observations appear first, followed by the 25 most negative; values depend on the published exposure convention. Data through close. Descriptive only, not a recommendation.

At a glance

50 tickers qualified. First five: URNM (10,682), KBE (10,062), CWH (8,642), TMUS (8,578), FSLR (7,454).

Vanna exposure extremes as of Nov 17, 2026 close
# Ticker Close Open interest Vanna per 100k OI
1 URNM 37.75 190,934 10,682
2 KBE 64.78 217,065 10,062
3 CWH 4.14 104,078 8,642
4 TMUS 167.90 300,099 8,578
5 FSLR 152.99 839,252 7,454
6 BEKE 18.41 312,463 7,377
7 PTON 5.19 823,589 7,157
8 CSIQ 7.80 159,398 7,111
9 LAES 1.09 910,869 6,805
10 EWC 58.69 407,551 6,436
11 STLA 3.64 641,066 6,402
12 HL 12.50 809,242 6,222
13 ASPI 1.37 166,476 6,105
14 RIVN 11.88 2,389,400 6,075
15 HIVE 1.43 330,037 6,073
16 BBBY 4.36 137,435 6,034
17 GRAB 3.18 2,222,457 6,016
18 OBE 9.25 119,019 5,910
19 RUN 7.72 629,747 5,877
20 VOD 15.22 177,162 5,515
21 UMC 14.14 348,453 5,514
22 IHI 56.94 136,703 5,413
23 PYPL 58.11 1,562,986 5,390
24 POET 4.40 1,105,763 5,345
25 TE 1.33 487,736 5,328
26 CMPX 0.61 178,949 -3,514
27 SG 12.18 302,110 -1,983
28 LQDA 56.73 266,463 -1,775
29 SGHC 10.96 199,386 -1,592
30 BRK.B 586.76 588,318 -1,140
31 XIFR 7.15 168,768 -1,033
32 HLF 15.57 139,049 -877
33 NUAI 3.20 415,468 -824
34 ZTS 83.48 190,134 -739
35 IBRX 6.26 661,106 -717
36 SLS 19.15 1,021,999 -557
37 CLOV 4.73 324,010 -394
38 ZETA 33.54 319,578 -308
39 NRGV 3.57 283,010 -252
40 PAGP 26.21 193,311 -247
41 ABCL 11.03 143,266 -218
42 PACB 1.82 239,412 -213
43 AEHR 49.74 131,292 -194
44 ABR 1.14 104,978 -193
45 UVIX 49.16 198,471 -128
46 U 50.36 672,685 -69
47 HE 8.36 117,493 -66
48 ETSY 82.62 154,361 12
49 INO 1.63 186,676 18
50 CAN 0.14 125,862 72

Screens describe what the data shows after the close. They are not trade recommendations; see the disclaimer and the methodology.